BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Live SK08 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Live SK08\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06725017-83@assetmemo.bio
DTSTAMP:20261121T005450Z
DTSTART;VALUE=DATE:20270701
DTEND;VALUE=DATE:20270702
SUMMARY:Live SK08: Phase 2 readout est. (NCT06725017)
DESCRIPTION:Live SK08\, phase 2\, Ulcerative Colitis.\nStudy: A Phase 2 Stu
 dy to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patien
 ts with Active Mild to Moderate Ulcerative Colitis\nEstimated primary comp
 letion: 1 July 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 live-sk08#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT06725017
URL:https://assetmemo.bio/drug/live-sk08#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
